Our Sponsors

Thank you to our sponsors for their ongoing support and contributions to the ALLG Scientific Meeting. We gratefully acknowledge their sponsorship.

Platinum Sponsors

AstraZeneca in Oncology
AstraZeneca is leading a revolution in oncology with the ambition to provide cures for cancer in every form, following the science to understand cancer and all its complexities to discover, develop and deliver life-changing medicines to patients. The Company’s focus is on some of the most challenging cancers. It is through persistent innovation that AstraZeneca has built one of the most diverse portfolios and pipelines in the industry, with the potential to catalyse changes in the practice of medicine and transform the patient experience. AstraZeneca has the vision to redefine cancer care and, one day, eliminate cancer as a cause of death.

For more information please visit astrazeneca.com.au

At Janssen Oncology, we have a bold vision – the elimination of cancer. This is what drives us to push the boundaries of science to help patients live cancer-free for longer than ever before. On the back of 30 years of innovation in oncology, our first-in-class therapies in solid tumors and hematological malignancies have extended lives and established new standards of care. Yet we continue to pursue every avenue to suppress, destroy and ultimately eliminate cancer – seeking not just incremental, but monumental change as we concentrate on where we can make the biggest difference. We focus on making hope and possibility a reality. Harnessing cutting-edge research platforms for personalized medicines, we continue to pursue the most compelling science to give an increasing number of people more time to live well, live longer and live cancer-free.

Gold Sponsor

Astellas is a global pharmaceutical company, working at the forefront of healthcare change to turn innovative science into value for patients. 

Silver Sponsors

AbbVie’s mission is to discover and deliver innovative medicines that solve serious health issues today and address the medical challenges of tomorrow.

Amgen is committed to unlocking the potential of biology for patients suffering from serious illnesses by discovering, developing, manufacturing and delivering innovative human therapeutics.

BeiGene is a global oncology company that is discovering and developing innovative treatments that are more affordable and accessible to cancer patients worldwide.

Bristol Myers Squibb is a global biopharmaceutical company whose mission is to discover, develop and deliver innovative medicines that help patients prevail over serious diseases.

Gilead and Kite Oncology are creating the future of oncology. From antibody-drug conjugates and small molecules to cell therapy-based approaches, our R&D programs and partnerships are creating possibilities for people with overlooked, underserved and difficult -to-treat cancers.

Jazz Pharmaceuticals is a global Biopharmaceutical Company whose purpose is to innovate to transform the lives of patients and their families. We are dedicated to developing life-changing medicines for people.

Lilly is a global healthcare leader that unites caring with discovery to create medicines that make life better for people around the world.

The Malaghan Institute of Medical Research is an independent biomedical research institute based in Wellington, New Zealand. The Malaghan Institute specialises in the immune system, and how it can be harnessed to improve human health.

Menarini is a multinational biopharmaceutical company with a presence in more than 100 countries, and offers a wide range of prescription, non-prescription, biological and highly specialized treatments.

Mendus develops novel immunotherapies to prevent or delay tumor recurrence. Its lead product vididencel is a whole cell-based cancer vaccine applied as AML maintenance treatment.

We use the power of leading-edge science to save and improve lives around the world. For more than 130 years, we have brought hope to humanity through the development of important medicines and vaccines.

Novartis is improving the lives of more than 2.8 million patients across Australia and New Zealand through our medicines.

One way or another, cancer touches all our lives. This motivates all of us at Pfizer, and we share that goal with healthcare providers, patient advocates, caregivers, biopharma companies, and everyone living with cancer.

Phebra, an Australian owned company, is an active supporter of Australian research. Phebra proudly developed and continues to manufacture Phenasen (arsenic trioxide injection) used in the APML4 and APML5 studies.

It’s personal - We take a personalised approach to cancer care, from diagnostics to treatments. If you share our passion and commitment, let’s join forces!

Servier is governed by a non-profit Foundation that aspires to have a meaningful social impact, both for patients and for a sustainable world.

Takeda is a global R&D-driven biopharmaceutical leader headquartered in Japan, committed to bringing Better Health and a Brighter Future to patients by translating science into highly-innovative medicines.